BETH C. SEIDENBERG - Director at Kyverna Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
KYTX on Nasdaq
All Insider Reports
All Insider Reports

BETH C. SEIDENBERG - trading volume in the past year for Kyverna Therapeutics, Inc.

Holdings reported by BETH C. SEIDENBERG for Kyverna Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 869,317 $6,519,877 $7.50 18 Dec 2025 Indirect
Common Stock 16,634 $130,244 $7.83 18 Dec 2025 Direct
Stock Option (right to buy) 65,351 29 May 2025 Direct Common Stock

Transactions reported by BETH C. SEIDENBERG for Kyverna Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.